表紙
市場調査レポート

医薬品偽造防止技術の市場分析・予測 (2016-2026年):RFID・タガント・バーコード・ホログラム/OVD・その他

Pharmaceutical Anti-Counterfeiting Technologies Market Forecast 2016-2026: RFID, Taggants, Barcodes, Holograms/OVD and Others

発行 Visiongain Ltd 商品コード 204744
出版日 ページ情報 英文 226 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=144.09円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
医薬品偽造防止技術の市場分析・予測 (2016-2026年):RFID・タガント・バーコード・ホログラム/OVD・その他 Pharmaceutical Anti-Counterfeiting Technologies Market Forecast 2016-2026: RFID, Taggants, Barcodes, Holograms/OVD and Others
出版日: 2016年04月26日 ページ情報: 英文 226 Pages
概要

世界の医薬品偽造防止技術の収益規模は2016年から2026年にかけて大きく拡大すると予測されています。偽造医薬品利用の拡大、政府による義務化、FDAイニシアチブ、技術的発展、RFID部門の急成長などの要因が2026年にかけての売上を推進する見通しです。

当レポートでは、世界の医薬品偽造防止技術の市場を調査し、医薬品偽造とその対策の現状、医薬品偽造防止技術の技術区分・地域/主要国別の動向、売上予測、市場成長への影響因子の分析、新たな技術開発の動向、主要企業のプロファイル、定性分析、専門家へのインタビュー、将来の展望などをまとめています。

第1章 調査概要

第2章 医薬品偽造:イントロダクション

  • 医薬品偽造:製薬産業にとっての悩みの種
  • 最もよく偽造される薬剤
  • 偽造薬剤のタイプ
    • 偽造品としての品質不良医薬品
    • 医薬品有効成分 (API) の世界的なアウトソーシング
  • 医薬品偽造の理由
  • 偽造薬剤の製造方法
    • サプライチェーンに溶け込む偽造薬剤
    • 医薬品流通システム内の不正
  • 医薬品偽造におけるインターネットの役割
    • オンライン薬局:医薬品偽造にとっての安価な流通システム
    • 合法オンライン薬局:投薬の便利かつ迅速な方法
    • オンライン薬局の信頼性の検証
  • 医薬品偽造:世界的なコスト
    • 消費者への影響
    • 医療従事者への影響
    • 製造業者への影響
    • 政府への影響
    • 世界の製薬産業への影響
  • Operation Pangea:ユーロポールによる対策
  • 医薬品偽造の促進因子
  • 主な偽造防止技術・アプリケーション
    • パッシブ偽造防止技術
    • アクティブ偽造防止技術
    • マスエンコーディング技術

第3章 世界の医薬品偽造防止技術市場の予測

  • 世界市場の実績
  • 世界市場の売上予測
  • 世界の医薬品偽造防止技術市場をリードするRFID
  • 市場シェアの変化の予測
  • 市場成長促進因子・阻害因子

第4章 医薬品バーコード市場

  • 偽造防止技術としてのバーコード
  • 市場実績
  • 売上予測
  • 市場成長促進因子・阻害因子

第5章 医薬品RFID市場

  • 偽造防止技術としてのRFID
  • 市場実績
  • 売上予測
  • 市場成長促進因子・阻害因子

第6章 医薬品タガント市場

  • 偽造防止技術としてのタガント
  • 市場実績
  • 売上予測
  • 市場成長促進因子・阻害因子

第7章 医薬品ホログラム/OVD市場

  • 偽造防止技術としてのホログラム
  • 市場実績
  • 売上予測
  • 市場成長促進因子・阻害因子

第8章 その他の技術市場:売上予測

第9章 国別市場の予測

  • 医薬品偽造防止技術市場の実績:地域別内訳
  • 国別市場の予測
  • 市場シェアの変化の見通し
  • 米国
  • EU5カ国
  • 日本
  • 中国
  • インド
  • ブラジル
  • ロシア
  • メキシコ

第10章 パイプライン

  • 通気性ホログラム (University of Michigan)
  • 3D摂食用バーコード
  • 3Dバーコード
  • ナノ粒子インク
  • チップ化医薬品
  • 医薬品識別のための安定同位体賦形剤
  • Agamatrixの診断ストリップ

第11章 主要企業

  • 主要企業:部門別
  • 3M
  • Alien Technologies
  • AlpVision
  • Angstrom Technologies
  • Authentix
  • Avery Dennison
  • Colorcon
  • Covectra
  • Everest Holovisions
  • Honeywell (Intermec)
  • Multi Packaging Solutions
  • ThermoFisher Scientific
  • TruTag Technologies
  • UPM Raflatac
  • Zebra Technologies

第12章 定性分析

  • SWOT分析
  • STEP分析

第13章 リサーチインタビュー

  • Fred Jordan氏 (Dr.):CEO, AlpVision
  • Jamie Barras氏 (Dr.):Technical Manager, CONPHIRMER

第14章 総論

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: PHA0111

Our new study reveals trends, R&D progress, and predicted revenues

Our new report discusses issues and events affecting the pharmaceutical anti-counterfeiting technologies market. You will find discussions, including qualitative analyses:

  • Increasing demand for pharmaceutical anti-counterfeiting technologies due to increasing cases of counterfeit drugs
  • Government requirements on serialisation in key national markets
  • Protection of brand name and revenues
  • Cost of implementing anti-counterfeiting technologies
  • Dilution impact on supply chains
  • Online market for pharmaceutical drugs

You will see discussions of technological, commercial, political and economic matters, with emphasis on the competitive landscape and business outlooks.

Besides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. There you find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT and STEP Analysis), company profiles and commercial developments.

Read the full transcripts of two exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales, including: Dr Fred Jordan, CEO of AlpVision, a world's leader in digital invisible technologies for product authentication and counterfeit protection. Dr Jamie Barras, technical manager of CONPHIRMER, a collaborative EU project aimed at developing a radiofrequency-spectroscopic sensor for identifying counterfeit medicines within packaging.

Discover How to Stay Ahead

Forecasts from 2016-2026 and other analyses reveal the commercial prospects

This study investigates commercial trends and revenues of the pharmaceutical anti-counterfeiting market from 2016 to 2026, as well as historical data. In particular it discusses sales potentials of the main submarkets of pharmaceutical anti-counterfeiting technology: barcodes, RFID, holograms/OVD and taggants. In addition, it includes qualitative analysis of anti-counterfeiting technology in the pipeline. This analysis also examines strengths and weaknesses of the pharmaceutical anti-counterfeiting market as well as the opportunities and threats it will face. It provides a discussion of the prominent companies with products already available or in the pipeline, who are vying for position in that industry. Furthermore, the study examines 8 leading national markets for pharmaceutical anti-counterfeiting, with analyses and revenue forecasts presented.

Discover sales predictions for the world market and submarkets

Predictions of leading products' sales - what's possible for those pharma anti-counterfeiting market

Along with revenue prediction for the overall world market, you see forecasts to 2026 for these five submarkets:

  • Barcodes
  • RFID
  • Holograms/OVD
  • Taggants
  • Other anti-counterfeiting technologies

Over the course of the forecast period, traditional barcode technology and new radio-frequency identification (RFID) technology will compete for market share.

With our investigation you gain business research and analysis with submarkets sales predictions and discussions. You find analysis of competition, as well as commercial drivers and restraints affecting each submarket. See what's likely to achieve the most success.

You gain competitive advantages by understanding the dynamics, opportunities and challenges facing the pharmaceutical anti-counterfeiting technologies market. As well as finding technologies that will likely to achieve the most success.

What are the prospects in the leading regions and countries?

In our study you will find individual revenue forecasts to 2026 for the leading regional and national markets:

  • US
  • Japan
  • EU5
  • China
  • India
  • Brazil
  • Russia
  • Mexico
  • Rest of the World

The US and the EU dominated shares of the market in 2015. However, the emerging markets will increase their market shares throughout the forecast period as the demand for such technologies will be greatest in areas where illegal counterfeiting is greatest.

Leading companies and the potential for market growth

Research and development - assess innovation, trends and possibilities

Overall world revenue for pharmaceutical anti-counterfeiting technologies will reach $3.4bn in 2015, our work forecasts. We predict strong revenue growth from 2016 to 2026. Rising consumption of counterfeit drugs, government regulatory mandates and FDA initiatives, technological advancements and the rapid growth of the RFID submarket will drive sales to 2026. Our work shows you which companies hold the greatest potential. See profiles of 15 leading companies, including these:

  • 3M
  • Alien Technology
  • AlpVision
  • Angstrom Technologies
  • Authentix
  • Avery Dennison
  • Colorcon
  • Covectra
  • Everest Holovisions
  • InkSure Technologies
  • Intermec
  • Multi Packaging Solutions
  • ThermoFisher Scientific
  • TruTag Technologies
  • UPM Raflatac
  • Zebra Technologies

A company profile gives you the following information:

  • Discussion of a company's activities and outlook
  • Recent financial results
  • Profiles of key anti-counterfeiting technologies
  • Assessment of recent developments - mergers and acquisitions (M&A), new products, and collaborations, including alliances, partnerships and joint ventures

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

How the pharma anti-counterfeiting market report helps you

This report features news, insights, the latest developments and an in depth survey of the pharmaceutical anti-counterfeiting technology market with up-to-date analysis as well as tables, graphs and charts. This report is a vital addition to gaining an understanding of this market sector and will give your company 'the edge' on your competitors. You cannot afford to be without this latest report from visiongain.

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Our 226 page report provides 50 tables and 66 figures covering 4 different submarkets. 8 national markets are covered in addition to 15 leading companies. Discover the most lucrative areas in the industry and the future market prospects. You will see financial results, interviews, trends, opportunities, and revenue predictions. Development of new and existing technologies in unison with an increasing occurrence of illegal counterfeit activity will increase worldwide sales of such products from 2016 to 2026, our study shows.

Benefit your work now through our updated study, gaining original industry and market analysis:

  • Revenue to 2026 for the global pharmaceutical anti-counterfeiting technology market - discover the sales potential of that industry
  • Revenues to 2026 for the leading submarkets of anti-counterfeiting technology - find sales predictions, seeing how they can compete and succeed
  • Forecasts to 2026 for 8 national markets in the Americas, Europe and Asia - discover the best countries and regions for commercial expansion
  • Activities of established, rising and emerging companies - hear about firms' products, capabilities, advances and outlooks, also with industry opinions
  • Discussions of R&D - investigate progress in that industry, finding technological and commercial outlooks and opportunities
  • Analysis of what stimulates and restrains the pharmaceutical anti-counterfeiting technology market - assess challenges and strengths for technology, their developers, producers and sellers, helping you compete and stay ahead.

visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Overview of the Pharmaceutical Anti-Counterfeiting Market
  • 1.2. Why You Should Read this Report
  • 1.3. How this Study Delivers
  • 1.4. Main Questions Answered by this Report
  • 1.5. Who is this Investigation For?
  • 1.6. Method of Research and Analysis
  • 1.7. Frequently Asked Questions (FAQs)
  • 1.8. Associated visiongain Reports
  • 1.9. About visiongain

2. Introduction to Pharmaceutical Counterfeiting

  • 2.1. Drug Counterfeiting: A Thorn in the Side of the Pharma Industry in Recent Years
    • 2.1.1. Regional Differences Hindering Information Exchange
    • 2.1.2. The Incidence of Counterfeited Pharmaceuticals is Increasing
    • 2.1.3. Asia and Europe are Counterfeiting Hotspots in 2014
  • 2.2. What are the Most Commonly Counterfeited Drugs?
  • 2.3. Types of Counterfeit Drugs
    • 2.3.1. Substandard Pharmaceutical Products as Counterfeits
    • 2.3.2. Global Outsourcing of Active Pharmaceutical Ingredients (APIs)
  • 2.4. Why are Drugs Counterfeited?
  • 2.5. Methods of Producing Pharmaceutical Counterfeits
    • 2.5.1. Moving Counterfeits into the Pharmaceutical Supply Chain
    • 2.5.2. Corruption Within the Pharmaceutical Distribution System
  • 2.6. The Role of the Internet in Pharmaceutical Counterfeiting
    • 2.6.1. Online Pharmacies: A Cheap Distribution System for Pharma Counterfeits
    • 2.6.2. Legal Online Pharmacies: A Convenient and quick Way of Dispensing Medication
    • 2.6.3. Verifying the Authenticity of Online Pharmacies
  • 2.7. The Global Costs of Pharmaceutical Counterfeiting
    • 2.7.1. The Impact of Pharmaceutical Counterfeiting on Consumers
    • 2.7.2. The Impact of Counterfeiting on Healthcare Providers
    • 2.7.3. The Impact of Counterfeiting on Pharma Manufacturers
    • 2.7.4. The Impact of Pharmaceutical Counterfeiting on Governments
    • 2.7.5. The Impact of Counterfeiting on the Global Pharmaceutical Industry
  • 2.8. Operation Pangea: Europol's Fight Against Online Counterfeiting
    • 2.8.1. Legislative Deficiencies Aiding Counterfeiting Operations
  • 2.9. Factors Driving Pharmaceutical Counterfeiting
    • 2.9.1. An Erratic Supply or Shortage of drugs Promotes Counterfeiting
    • 2.9.2. Price Differentials and High Price Medicines Drive People to Cheaper Counterfeit Alternatives
    • 2.9.3. Drug Misuse Creates a Market for Counterfeiting
    • 2.9.4. Trade Through Free-Trade Zones/Free Ports is an Important Route for Counterfeiters
    • 2.9.5. The Trade of Pharmaceuticals Through Several Intermediaries Helps Hide Counterfeit Drugs
    • 2.9.6. Counterfeiters Target Developed Markets
    • 2.9.7. Parallel Trade - A Counterfeiting Route in Europe
  • 2.10. Leading Anti-Counterfeiting Technologies and Applications
    • 2.10.1. Passive Anti-Counterfeiting Technologies
    • 2.10.2. Active Anti-Counterfeiting Technologies
    • 2.10.3. Mass Encoding Techniques

3. The Global Market for Pharmaceutical Anti-Counterfeiting Technologies, 2016-2026

  • 3.1. World Pharmaceutical Anti-counterfeiting Technologies Market in 2014 and 2015
    • 3.1.1. Breakdown of the World Pharmaceutical Anti-Counterfeiting Market by Technology in 2015
  • 3.2. World Pharmaceutical Anti-Counterfeiting Technologies Market: Sales Forecast 2016-2026
    • 3.2.1. World Pharmaceutical Anti-Counterfeiting Technologies Market: Sales Forecast, 2014-2020
    • 3.2.2. World Pharmaceutical Anti-counterfeiting Technologies Market: Sales Forecast, 2020-2026
  • 3.3. RFID Leads the World Pharmaceutical Anti-Counterfeiting Technologies Market
  • 3.4. How Will Market Shares Change to 2026?
  • 3.5. Drivers and Restraints for the Pharmaceutical Anti-Counterfeiting Technologies Market, 2016-2026

4. The Pharmaceutical Barcodes Market, 2016-2026

  • 4.1. Barcodes as Anti-counterfeiting Technology
  • 4.2. Pharmaceutical Barcodes Submarket in 2014 and 2015
  • 4.3. Pharmaceutical Barcodes Market: Sales Forecast 2016-2026
  • 4.4. Pharmaceutical Barcodes Market: Drivers and Restraints, 2016-2026

5. The Pharmaceutical RFID Submarket 2016-2026

  • 5.1. RFID as Anti-counterfeiting Technology
  • 5.2. Pharmaceutical RFID Market in 2014 and 2015
  • 5.3. Pharmaceutical RFID Market: Sales Forecast 2016-2026
  • 5.4. Pharmaceutical RFID Submarket: Drivers and Restraints 2016-2026
    • 5.4.1. Drivers of the of the Pharmaceutical RFID Submarket
    • 5.4.2. Restraints of the Pharmaceutical RFID Submarket

6. Pharmaceutical Taggants Submarket 2016-2026

  • 6.1. Taggants as Anti-counterfeiting Technology
  • 6.2. Pharmaceutical Taggants Submarket in 2014 and 2015
  • 6.3. Pharmaceutical Taggants Market: Sales Forecast 2016-2026
  • 6.4. Pharmaceutical Taggants Market: Drivers and Restraints 2016-2026

7. Pharmaceutical Holograms/OVD Market 2016-2026

  • 7.1. Holograms as Anti-Counterfeiting Technology
  • 7.2. Pharmaceutical Holograms/OVD Market in 2014 and 2015
  • 7.3. Pharmaceutical Holograms/OVD Market: Sales Forecast 2016-2026
  • 7.4. Pharmaceutical Holograms/OVD Market: Drivers and Restraints 2016-2026

8. Other Pharmaceutical Anti-Counterfeiting Technologies Market: Sales Forecast 2016-2026

9. National Markets for Pharmaceutical Anti-Counterfeiting Technology, 2016-2026

  • 9.1. Geographical Breakdown of the World Pharmaceutical Anti-Counterfeiting Market in 2014-2015
  • 9.2. World Pharmaceutical Anti-Counterfeiting Technologies Market: National Markets Forecast 2016-2026
  • 9.3. How Will National Market Shares Change by 2026?
  • 9.4. The US Pharmaceutical Anti-Counterfeiting Market
    • 9.4.1. The US Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
    • 9.4.2. Trends and Developments in the US Pharmaceutical Anti-Counterfeiting Market
  • 9.5. The EU5 Pharmaceutical Anti-Counterfeiting Technologies Market
    • 9.5.1. The EU5 Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
    • 9.5.2. EU5 Enforcement of Drug Serialisation in 2016
  • 9.6. The Japanese Pharmaceutical Anti-Counterfeiting Market
    • 9.6.1. The Japanese Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
    • 9.6.2. The Uptake of Anti-Counterfeit Technology in Japan
  • 9.7. The Chinese Pharmaceutical Anti-Counterfeiting Market
    • 9.7.1. The Chinese Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
    • 9.7.2. Chinese Pharmaceutical Anti-Counterfeiting Measures from Past to Present
  • 9.8. The Indian Pharmaceutical Anti-Counterfeiting Market
    • 9.8.1. The Indian Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
    • 9.8.2. India's Award Winning DAVA Project will Restore
  • 9.9. The Brazilian Pharmaceutical Anti-Counterfeiting Market
    • 9.9.1. The Brazilian Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
    • 9.9.2. Brazilian Anti-Counterfeiting Measures from Past to Present
  • 9.10. The Russian Pharmaceutical Anti-Counterfeiting Market
    • 9.10.1. The Russian Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
    • 9.10.2. Russia's New Anti-Counterfeiting Programme Due Q1 2017
  • 9.11. The Mexican Pharmaceutical Anti-Counterfeiting Market
    • 9.11.1. The Mexican Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
    • 9.11.2. Mexico Signs the Anti-Counterfeiting Trade Agreement

10. Pipeline for the Pharmaceutical Anti-Counterfeiting Market

  • 10.1. Breathable Holograms at the University of Michigan
  • 10.2. 3D Ingestible Barcodes
  • 10.3. 3D Barcodes
  • 10.4. Nanoparticle Ink
  • 10.5. Chipped Pharmaceuticals In Vivo
  • 10.6. Stable Isotope Excipients for Drug Identification
  • 10.7. Agamatrix Diagnostic Strip

11. Leading Companies in the Pharmaceutical Anti-Counterfeit Market

  • 11.1. Leading Pharmaceutical Anti-Counterfeiting Technology Manufacturers by Segment in 2016
  • 11.2. 3M Overview
    • 11.2.1. 3M Financial Figures
  • 11.3. Alien Technologies Overview
    • 11.3.1. Recent Developments at Alien Technologies
  • 11.4. AlpVision Overview
    • 11.4.1. AlpVision Products
    • 11.4.2. Recent developments at AlpVision
  • 11.5. Angstrom Technologies Overview
  • 11.6. Authentix Overview
    • 11.6.1. Product-Specific Track-and-Trace Solutions
    • 11.6.2. Packaging Solutions
  • 11.7. Avery Dennison Overview
    • 11.7.1. Avery Dennison Financial Figures
  • 11.8. Colorcon Overview
    • 11.8.1. Colorcon's Taggants: On-Dose ID
    • 11.8.2. Recent Developments for Colorcon
  • 11.9. Covectra Overview
    • 11.9.1. Recent Developments at Covectra
  • 11.10. Everest Holovisions Overview
  • 11.11. Honeywell Acquires Intermec
    • 11.11.1. Honeywell Financial Figures
  • 11.12. Multi Packaging Solutions Overview
    • 11.12.1. MPS Recent Developments
  • 11.13. ThermoFisher Scientific Overview
    • 11.13.1. ThermoFisher Scientific Financial Figures
    • 11.13.2. Recent Developments at ThermoFisher Scientific
  • 11.14. TruTag Technologies Overview
    • 11.14.1. Recent Developments at TruTag Technologies
  • 11.15. UPM Raflatac Overview
    • 11.15.1. UPM Raflatac Recent Developments
  • 11.16. Zebra Technologies Overview
    • 11.16.1. Zebra Technologies Financial Figures
    • 11.16.2. Zebra Technologies Recent Developments

12. Qualitative Analysis of the Pharmaceutical Anti-Counterfeiting Technologies Market, 2016-2026

  • 12.1. SWOT Analysis of World Pharmaceutical Anti-counterfeiting Technologies Market, 2016-2026
  • 12.2. Strengths of the Anti-Counterfeiting Technology Market
    • 12.2.1. Growing Interest from Pharmaceutical Companies in Tackling Counterfeiting
    • 12.2.2. Organisations Promoting Awareness and Implementation of Anti-Counterfeiting Solutions
    • 12.2.3. Track-and-Trace Solutions Boosting Supply Chain Efficiency
    • 12.2.4. New Technologies Providing More Comprehensive Anti-Counterfeiting Protection
    • 12.2.5. Litigation Proceedings over Counterfeit Products Affecting Profitability
  • 12.3. Weaknesses
    • 12.3.1. Lack of Standardisation Across the Industry Will Impede Technology Adoption
    • 12.3.2. Insufficient Quantitative Measurement of the Effectiveness of Anti-Counterfeiting Technologies
    • 12.3.3. Technology Reliability and the Ease of Integration into Manufacturing Processes
    • 12.3.4. Lack of Cooperation Between Governmental Organisations Aids Drug Counterfeiters
  • 12.4. Opportunities
    • 12.4.1. Constantly Evolving Technologies Allows for Product Innovation
    • 12.4.2. Anti-Counterfeiting Technologies for the Prevention of Online Fraud
  • 12.5. Threats
    • 12.5.1. High Volume of Counterfeiting Activities Could Devalue Anti-Counterfeiting Solutions
    • 12.5.2. Developing Countries Lack Infrastructure to effectively Deal with Counterfeiting
    • 12.5.3. Rate of Innovation May be Outpaced by Counterfeiters
  • 12.6. STEP Analysis of the World Pharmaceutical Anti-Counterfeiting Technologies Market, 2016-2026
  • 12.7. Social Factors Affecting the Pharmaceutical Anti-Counterfeiting Market
    • 12.7.1. Weak Enforcement of Legislation
    • 12.7.2. Corruption is a Hindrance to Eradicating Pharmaceutical Counterfeiting
    • 12.7.3. Changing Public Perception and Consumer Education
    • 12.7.4. Concerns Over Privacy
  • 12.8. Technological Factors
    • 12.8.1. Smartphone Read and Verify: A Customer Empowerment Tool
    • 12.8.2. US FDA Counterfeit Detection Device
    • 12.8.3. UV and IR Inks Being Used Covertly for Increased Security
    • 12.8.4. Potential Replacements for Barcodes
    • 12.8.5. SigNature DNA
  • 12.9. Economic Factors
    • 12.9.1. Implementation Costs of Anti-Counterfeiting Technologies
    • 12.9.2. Anti-Counterfeiting Technologies Require R&D Investment
  • 12.10. Political Factors
    • 12.10.1. Who: The IMPACT Programme
    • 12.10.2. Interpol Operations
    • 12.10.3. Anti-Counterfeiting Trade Agreement (ACTA)
    • 12.10.4. The Fagan Case: Effects of Litigation on Players in the Drug Supply Chain
    • 12.10.5. Legislations for Supply Chain Security
    • 12.10.6. E-pedigree: Catalyst for Product Serialisation
    • 12.10.7. UK MHRA: Falsified Medical Products Strategy
    • 12.10.8. EU's Falsified Medicines Directive

13. Research Interview

  • 13.1. Interview with Dr Fred Jordan, CEO of AlpVision
    • 13.1.1. On AlpVision and its Products
    • 13.1.2. On the Problem of Counterfeiting Now and in the Future
  • 13.2. Interview with Dr Jamie Barras, Technical Manager for CONPHIRMER
    • 13.2.1. On the CONPHIRMER Consortium
    • 13.2.2. On the Problem of Counterfeiting Now and in the Future

14. Conclusions

  • 14.1. Pharmaceutical Anti-Counterfeiting Technologies: A Growing Market
  • 14.2. Leading Pharmaceutical Anti-Counterfeiting Technologies Submarkets in 2015-2026
  • 14.3. Leading National Markets in 2015
  • 14.4. The Future of the Pharmaceutical Anti-Counterfeiting Technologies
    • 14.4.1. Government Mandates Will Fuel Growth in the Market
    • 14.4.2. The US Will Continue to Dominate the Market
    • 14.4.3. New Directives Will Ensure track-and-Trace Market Leadership
    • 14.4.4. European Preference for Mandated 2D Barcode Technology
    • 14.4.5. Enhances Regulation of Online Pharmacies Necessary for Anti-Counterfeiting Technologies to be Effective
    • 14.4.6. Market Expansion Will be Dependent on the Development of Industry-wide Standards
    • 14.4.7. What Will Succeed in the Pharmaceutical Anti-Counterfeiting Technologies Market?
  • Associated visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Report Evaluation Form

List of Tables

  • Table 1.1: World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2026
  • Table 2.1: Global Reported Incidents of Drug Counterfeiting, 2009-2014
  • Table 2.2: Global Reported Incidents of Drug Counterfeiting by Region & Regional Percentage (%), 2014
  • Table 2.3: Classification of Counterfeit Pharmaceutical Products
  • Table 2.4: Characteristics of an Ideal Anti-counterfeiting Technology
  • Table 2.5: Advantages and Disadvantages of Overt and Covert Technologies
  • Table 2.6: Types of Anti-counterfeiting Technologies Used in the Pharmaceutical Industry by Category
  • Table 3.1: World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Technology, 2014 and 2015
  • Table 3.2: World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2026
  • Table 3.3: World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: CAGR (%) by Technology in 2014-2020, 2020-2026 and 2014-2026
  • Table 3.4: World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Market Shares (%) by Technology, 2015, 2020 and 2026
  • Table 4.1: Comparison of 2D Barcode and RFID Technology
  • Table 4.2: Barcodes Submarket Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2026
  • Table 5.1: RFID Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2026
  • Table 6.1: Taggants Submarket Forecast: Revenues ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
  • Table 7.1: Holograms/OVD Submarket Forecast: Revenues ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
  • Table 8.1: Others Submarket Forecast: Revenues ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
  • Table 9.1: World Pharmaceutical Anti-Counterfeiting Technologies Market: Revenues ($m) by Region, 2014 and 2015
  • Table 9.2: World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%) by Region, 2016-2026
  • Table 9.3: World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Market Shares (%) by Region, 2015, 2020 and 2026
  • Table 9.4: US Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 9.5: EU5 Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 9.6: Japanese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 9.7: Chinese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 9.8: Indian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 9.9: Brazilian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 9.10: Russian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 9.11: Mexican Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 11.1: Leading RFID Technology Manufacturers, 2016
  • Table 11.2: Leading Holographic Labelling Technology Manufacturers, 2016
  • Table 11.3: Leading Taggants Technology Manufacturers, 2016
  • Table 11.4: Other Leading Anti-counterfeiting Technology Manufacturers, 2016
  • Table 11.5: 3M: Revenue ($m) and Revenue Shares (%) by Business Segment, 2015
  • Table 11.6: 3M Historical Sales: Revenue ($m), AGR (%), 2010-2015
  • Table 11.7: Alien Technologies: Portfolio of RFID Readers, 2016
  • Table 11.8: Alien Technologies: Portfolio of RFID Inlays and Their Relative Performances in Pharma Applications, 2016
  • Table 11.9: AlpVision: Portfolio of Pharmaceutical Anti-counterfeiting Solutions, 2016
  • Table 11.10: Angstrom Technologies: Portfolio of Anti-Counterfeiting Solutions, 2016
  • Table 11.11: Avery Dennison: Portfolio of RFID Inlays for Use in Pharmaceuticals, 2016
  • Table 11.12: Avery Dennison: Revenue ($m) and Revenue Shares (%) by Business Segment, 2015
  • Table 11.13: Avery Dennison Historical Sales: Revenue ($m), AGR (%), 2010-2015
  • Table 11.14: Everest Holovision: Portfolio of Pharma Products and Applications, 2016
  • Table 11.15: Honeywell's Intermec: Portfolio of Products and Descriptions, 2016
  • Table 11.16: Honeywell Historical Sales: Revenue ($m), AGR (%), 2010-2015
  • Table 11.17: ThermoFisher Scientific Historical Sales: Revenue ($m), AGR (%), 2010-2015
  • Table 11.18: UPM Raflatac: Portfolio of Product Groups and Descriptions, 2016
  • Table 11.19: Zebra Technologies Historical Sales: Revenue ($m), AGR (%), 2010-2014
  • Table 12.1: SWOT Analysis of World Pharmaceutical Anti-counterfeiting Technologies Market, 2016-2026
  • Table 12.2: Selected Instances of Counterfeiting Activities, 2011-2016
  • Table 12.3: STEP Analysis of World Pharmaceutical Anti-counterfeiting Technologies Market, 2016-2026

List of Figures

  • Figure 1.1: World Anti-counterfeiting Market Segmentation by Technology Overview
  • Figure 2.1: Global Reported Incidents of Drug Counterfeiting, 2009-2014
  • Figure 2.2: Global Reported Incidents of Drug Counterfeiting by Region, 2014
  • Figure 2.3: Global Reported Incidents of Drug Counterfeiting by Regional Percentage (%), 2014
  • Figure 2.4: Most Common Types of Drugs Counterfeited in Developed and Emerging Countries, 2016
  • Figure 2.5: Flow Chart of the Route Taken by Counterfeit Pharma Products Entering the Legal Supply Chain
  • Figure 2.6: Basic Components of a RFID System: Antenna, Transceiver and Transponder
  • Figure 3.1: World Pharmaceutical Anti-Counterfeiting Technologies Market: Revenues ($m) by Technology, 2014
  • Figure 3.2: World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Technology, 2015
  • Figure 3.3: World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
  • Figure 3.4: World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
  • Figure 3.5: World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Technology, 2016-2026
  • Figure 3.6: World Pharmaceutical Anti-counterfeiting Market Forecast: CAGR (%) by Technology in 2014-2020 and 2020-2026
  • Figure 3.7: World Pharmaceutical Anti-counterfeiting Market Forecast: CAGR (%) by Technology in 2014-2026
  • Figure 3.8: World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Technology, 2015
  • Figure 3.9: World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Technology, 2020
  • Figure 3.10: World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Technology, 2026
  • Figure 3.11: World Pharmaceutical Anti-counterfeiting Technologies Market: Drivers and Restraints, 2016-2026
  • Figure 4.1: Barcodes Market Forecast: Revenues ($m), 2016-2026
  • Figure 4.2: Barcodes Market Forecast: AGR (%), 2016-2026
  • Figure 4.3: Barcodes Market Forecast: Drivers and Restraints, 2016-2026
  • Figure 5.1: RFID Market Forecast: Revenues ($m), 2014-2026
  • Figure 5.2: RFID Market Forecast: AGR (%), 2016-2026
  • Figure 5.3: RFID Market Forecast: Drivers and Restraints, 2016-2026
  • Figure 6.1: Taggants Submarket Forecast: Revenues ($m), 2016-2026
  • Figure 6.2: Taggants Submarket Forecast: AGR (%), 2016-2026
  • Figure 6.3: Taggants Submarket Forecast: Drivers and Restraints, 2016-2026
  • Figure 7.1: Holograms/OVD Submarket Forecast: Revenue ($m), 2016-2026
  • Figure 7.2: Holograms/OVD Submarket Forecast: AGR (%), 2016-2026
  • Figure 7.3: Holograms/OVD Market Forecast: Drivers and Restraints, 2016-2026
  • Figure 8.1: Others Submarket Forecast: Revenue ($m), 2016-2026
  • Figure 8.2: Others Submarket Forecast: AGR ($m), 2016-2026
  • Figure 9.1: World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Region, 2014
  • Figure 9.2: World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Region, 2015
  • Figure 9.3: World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Region, 2016-2026
  • Figure 9.4: World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2015
  • Figure 9.5: World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2020
  • Figure 9.6: World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2026
  • Figure 9.7: US Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), 2016-2026
  • Figure 9.8: US Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
  • Figure 9.9: EU5 Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
  • Figure 9.10: EU5 Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
  • Figure 9.11: Japanese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
  • Figure 9.12: Japanese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
  • Figure 9.13: Chinese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
  • Figure 9.14: Chinese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
  • Figure 9.15: Indian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
  • Figure 9.16: Indian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
  • Figure 9.17: Brazilian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
  • Figure 9.18: Brazilian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
  • Figure 9.19: Russian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
  • Figure 9.20: Russian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
  • Figure 9.21: Mexican Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
  • Figure 9.22: Mexican Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
  • Figure 11.1: 3M: Revenue Shares (%) by Business Segment, 2015
  • Figure 11.2: 3M Historical Sales: Revenue ($m), 2010-2015
  • Figure 11.3: Authentix's Global Monitoring Service: A Three Step Programme
  • Figure 11.4: Avery Dennison: Revenue Shares (%) by Business Segment, 2015
  • Figure 11.5: Avery Dennison Historical Sales: Revenue ($m), 2010-2015
  • Figure 11.6: Honeywell Historical Sales: Revenue ($m), 2010-2015
  • Figure 11.7: ThermoFisher Scientific Historical Sales: Revenue ($m), 2010-2015
  • Figure 11.8: Zebra Technologies Historical Sales: Revenue ($m), 2010-2014
  • Figure 12.1: EU Supply Chain Authentication Strategy, 2016
  • Figure 12.2: US Supply Chain Authentication Strategy, 2016
  • Figure 13.1: Leading Submarkets for the Pharmaceutical Anti-Counterfeiting Technologies Market: Revenue ($m) from 2015-2026
  • Figure 13.2: Leading National Markets for the Pharmaceutical Anti-Counterfeiting Technologies Market: Revenue ($m) from 2015-2026

Companies Listed

  • 3M
  • Adhesives Research
  • Affymetrix
  • Ahura Scientific
  • Alien Technology
  • AlpVision
  • Amerisource
  • AmerisourceBergen (Amgen)
  • AND Automation
  • Angstrom Technologies
  • Angstrom Technologies
  • Apoteket
  • Applied DNA Sciences
  • ARmark Authentication Technologies
  • AstraZeneca
  • Authentix
  • Avery Dennison
  • Axway
  • Baxter
  • Bp Media
  • Cal Sierra
  • Camdata
  • Cardinal Health
  • Cellular Bioengineering
  • CFC International
  • Colorcon
  • Cortegra
  • Covectra
  • DataDot Technology
  • DataTrace DNA
  • Digital China
  • Domino
  • DuPont
  • Everest Holovisions
  • Genentech
  • GIS
  • GlaxoSmithKline (GSK)
  • Hart Systems
  • Hoffmann-La Roche
  • Hologram Industries
  • Holomex
  • Holovisions
  • Honeywell
  • Image Solutions
  • Impinj
  • Inabata
  • Ingenia Technology
  • Inksure Technologies
  • Intermec Technologies
  • International Ink Company
  • Johnson & Johnson (J&J)
  • Kodak
  • LaserLock
  • Life Technologies
  • McKesson
  • Menasha Corporation
  • MicroTag Temed
  • Microtrace Solutions
  • Millennium Pharmaceuticals
  • Motorola
  • Multi Packaging Solutions (formerly Chesapeake)
  • Nanotech Security Corp
  • Neri Labels
  • Novartis
  • Novavision
  • OEP Technologie BV
  • Pacific Holographics
  • Paulaur
  • Pera Innovation
  • Pfizer
  • Product Presentations
  • ROC IT Solutions
  • Roche
  • Sanofi
  • SciClone
  • Shanghai Ruizhang Investment
  • SICPA
  • Siemens
  • Smartrac
  • Softmat
  • Spectra Systems Corporation
  • Sun Chemical
  • Symbol Technologies
  • Systech
  • Tagsys RFID
  • Texas Instruments
  • The Carlyle Group
  • ThermoFisher Scientific
  • Toya Aluminium
  • TruTag Technologies
  • UPM Raflatac
  • UPM-Kymmene Corporation
  • Voxtel
  • Webscan
  • WuXi PharmaTech
  • Zebra Technologies
Back to Top